Molecular Partners (MOLN) Stock Chart & Stock Price History $3.53 -0.17 (-4.59%) Closing price 08/1/2025 03:46 PM EasternExtended Trading$3.67 +0.14 (+3.97%) As of 08/1/2025 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Molecular Partners Stock Price Performance The Molecular Partners (MOLN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 48.62%, with a year-to-date return of -25.68%. In the past month, the stock has decreased 7.11%, reflecting recent market activity. As of the latest close, Molecular Partners traded at $3.53 with a market cap of $142.54 million and volume of 424 shares. Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-9.02%1 Month Performance-7.11%3 Month Performance-13.48%Year-To-Date Performance-25.68%1 Year Performance-48.62% MOLN Stock Chart for Saturday, August, 2, 2025 MOLN Chart by TradingView Molecular Partners Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$3.68$3.53-4.10%$3.53$3.41424 shs$142.54 million07/31/2025$3.77$3.68-2.33%$3.70$3.70270 shs$148.64 million07/30/2025$3.80$3.77-0.79%$3.85$3.651,116 shs$152.17 million07/29/2025$3.88$3.80-2.09%$3.96$3.921,380 shs$153.40 million07/28/2025$4.01$3.88-3.22%$3.95$3.94938 shs$156.67 million07/25/2025$3.89$4.01+3.09%$4.00$3.832,113 shs$161.88 million07/24/2025$3.89$3.89-0.03%$4.00$3.831,976 shs$157.04 million07/23/2025$3.85$3.89+1.17%$3.90$3.90889 shs$150.67 million07/22/2025$3.79$3.85+1.34%$3.85$3.73874 shs$155.26 million07/21/2025$3.63$3.79+4.66%$3.87$3.781,567 shs$153.20 million Get the Latest News and Ratings for MOLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$3.66$3.63-0.93%$3.60$3.60408 shs$146.38 million07/17/2025$3.62$3.66+1.11%$3.66$3.571,367 shs$147.73 million07/16/2025$3.55$3.62+1.86%$3.70$3.551,825 shs$146.14 million07/15/2025$3.55$3.55+0.08%$3.62$3.57629 shs$143.45 million07/14/2025$3.55$3.55+0.11%$3.55$3.51735 shs$143.33 million07/11/2025$3.63$3.55-2.18%$3.59$3.59497 shs$143.17 million07/10/2025$3.65$3.63-0.66%$3.60$3.551,050 shs$146.38 million07/09/2025$3.58$3.65+1.93%$3.68$3.583,313 shs$147.35 million07/08/2025$3.61$3.58-0.83%$3.68$3.583,313 shs$144.54 million07/07/2025$3.72$3.61-2.96%$3.76$3.612,184 shs$145.77 million07/04/2025$3.72$3.72$3.76$3.74638 shs$150.20 million07/03/2025$3.80$3.72-2.11%$3.76$3.74638 shs$150.21 million07/02/2025$3.69$3.80+2.98%$3.76$3.74638 shs$153.44 million07/01/2025$3.79$3.69-2.64%$3.84$3.71710 shs$149.00 million Related Companies Relay Therapeutics Stock Chart Septerna Stock Chart Phathom Pharmaceuticals Stock Chart Rapport Therapeutics Stock Chart Evolus Stock Chart Bicycle Therapeutics Stock Chart Zevra Therapeutics Stock Chart Tyra Biosciences Stock Chart Keros Therapeutics Stock Chart Tourmaline Bio Stock Chart Receive MOLN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Molecular Partners and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MOLN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Molecular Partners AG Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Molecular Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
